Is Amble Legit? Amble Weight Loss Reviews, GLP-1 Prices and the Real Cost

Amble Weight Loss Reviews: A 4.6-Star Trustpilot and an F From the BBB

Amble's reviews split into two records that disagree, and both are real. The joinamble.com Trustpilot profile holds a 4.6/5 TrustScore from 4,487 reviews (Trustpilot, read September 7, 2026), 2,741 of them in the last twelve months, on a profile Amble has claimed since January 2024 under the category "Weight Loss Service" — so unlike Hims, Hers or Noom, this score is about the GLP-1 program itself. The distribution is bimodal: 81% five-star, 6% four, 1% three, 1% two and 11% one-star. Amble pays for a Trustpilot subscription and has replied to 100% of negative reviews.

The Better Business Bureau tells a different story. Amble Health is rated F and is not accredited, with 363 complaints filed in the last three years, 191 of them marked "failure to respond" and 11 unresolved (file opened May 16, 2024). The BBB file lists the company at a Houston, Texas suite address, while Amble's own Terms give Cortland, Ohio — one of several small inconsistencies below.

Read together, the two records describe an operational business, not a clinical one. In the twenty most recent one-star Trustpilot reviews (August 2 to September 3, 2026) the themes were automatic refills billed before an order shipped (11 reviews), unreachable support (9), refused refunds (9) and undelivered or wrong orders (8) — themes overlap, so the counts exceed 20; a September 3 reviewer called the chat and email support unanswerable. The five-star reviews from the same weeks praise the opposite qualities — approval "in less than a week", easy signup, named support staff and real weight loss. The BBB complaints repeat the one-star themes and add a July 2026 complaint that Amble demanded a $100 payment before closing an account, which matches the cancellation fee in its own Refund Policy.

What Amble Sells and What Amble GLP-1 Costs in September 2026

Verified on joinamble.com/glp-1-injections on September 7, 2026. Amble sells compounded semaglutide ("Compounded GLP-1") and compounded tirzepatide ("Compounded GLP-1 + GIP") by injection only — no brand Wegovy, Zepbound or Ozempic, no Foundayo, no oral option. The GLP-1 page says medication is dispensed by U.S. "503A pharmacies" and "503B outsourcing facilities" that Amble assigns and does not name; its help center states it is "unable to accommodate requests for specific pharmacies". Every plan includes the online assessment, physician review, supplies, cold shipping, 24/7 messaging and scheduled check-ins, and there is no membership fee.

The $99 Plan That Isn't There, and Six Other Contradictions

Amble's homepage says "plans starting at $99 per month", but no $99 GLP-1 plan exists on joinamble.com: the lowest GLP-1 price on any page is $135/month on a six-month prepayment, and the cheapest products at any price are non-GLP-1 add-ons. We checked every product page on the site on September 7, 2026 (homepage, GLP-1 page). The pattern repeats elsewhere, and it matters because a buyer comparing providers on the headline number will be comparing a figure Amble does not charge:

1. Homepage "starting at $99/month" versus a $135/month floor.
2. Two plan tables on the same GLP-1 page: the first prices six months at $135/month, the second at $145/month.
3. Compounded tirzepatide priced at $329, $229 and $250 on one landing page and not priced at all on the product page.
4. The Terms of Service say "we will refund your initial payment" if a prescription cannot be provided because the treatment is medically inappropriate; the Refund Policy says consultation fees are non-refundable "including cases where a medication is not prescribed".
5. "250,000+ patients" in the homepage hero and "100,000+ members treated" lower on the same page.
6. A "4.6 • 2000+ reviews" badge on the site against 4,487 reviews on Trustpilot.
7. Cortland, Ohio in the Terms and press releases; Houston, Texas on the BBB file; Southington, Ohio as the registered address in the court docket.

None of these is evidence of a scam. They are evidence of a marketing operation moving faster than its fact-checking — which is exactly the failure mode the one-star reviews describe on the billing side.

What You Agree To: Amble's Terms, Refund Policy and Cancellation Fee

Amble's commitment terms are the strictest among the no-membership programs on our list: multi-month plans are a non-refundable commitment for the full term once medication is dispensed, cancellation requests need 15 days' notice before the next billing date, a $100 fee applies to cancel a prescribed order before it ships, and all medication sales are final. The wording, from the Terms of Service (last updated May 8, 2025), the Refund Policy and the help center:

• “These programs are non-refundable once medication has been dispensed, even partially.”
• "All cancellation requests must be received at least fifteen (15) days before your next billing date."
• "If the order has already been prescribed but has not yet been shipped, a $100 cancellation fee will apply." The help center calls the same charge "a $100 nonrefundable clinical fee".
• “All medication sales are final.” and “Telehealth consultation fees are non-refundable. This includes cases where a medication is not prescribed.”
• “All purchases are subscription-based and automatically renew according to the billing terms presented at checkout.” Refills are automatic; pauses need 15 days' notice.
• From the pricing disclaimer on its GLP-1 pages, not the Terms: "Any 'same price at every dose' promotion expires within 24 hours of any price updates. Introductory or promotional pricing, including 'first month' offers, are not governed by the 'same price per dose' policy." — so the price lock advertised on landing pages is conditional (source).
• Disputes go to binding individual arbitration with a class-action waiver, under Ohio law.

For comparison, the tracked no-membership providers we rank highest publish month-to-month billing with no cancellation fee; the terms are the single biggest practical difference between Amble and those programs, and the reason the six-month price should be read as a $810 commitment rather than a $135 monthly rate.

The Regulatory and Legal Record

Has Amble received an FDA warning letter?

No letter found. We searched the FDA's warning-letter database for "Amble" on September 7, 2026 and found no letter issued to Amble Health (FDA search); a control search for "semaglutide" returned the expected 2025–2026 letters to other telehealth and peptide sellers, so the empty result is real. Amble's compounded products are, like all compounded drugs, not FDA-approved finished products, and Amble names no dispensing pharmacy, which is a transparency deduction under our methodology.

Was Amble sued by Novo Nordisk, and what happened?

Yes — Novo Nordisk v. Amble Health, filed May 21, 2025, was dismissed on March 17, 2026 for lack of standing. Novo Nordisk sued Amble Health, Inc. in the U.S. District Court for the Northern District of Ohio (case 4:25-cv-01048), alleging under the Lanham Act that Amble sold unapproved compounded drugs purporting to contain semaglutide as "personalized" products while they were mass-produced in contravention of federal law, and that its marketing was likely to confuse and deceive consumers (On the Pen, August 28, 2025). On March 17, 2026 the court dismissed the case for lack of subject-matter jurisdiction, holding that Novo had failed to plausibly allege an injury in fact, and on March 31, 2026 confirmed the dismissal was without prejudice (Mealey's). That is a decision about Novo's standing to sue; the court did not rule on whether the allegations were true, and Novo can refile.

Who runs Amble?

Amble Health Inc., an Ohio corporation led by CEO Joey Stiver, with no named medical director. Amble Health Inc. is an Ohio corporation whose Terms state that it "does not engage in the practice of medicine" and only facilitates access to third-party providers; the site names no medical director, saying only that providers "are physicians" licensed in all 50 states. The only named professional on the site is a behavioural neuroscientist with a PhD, not a physician. The CEO, Joey Stiver, discloses on his own website a federal indictment and felony conviction from an earlier peptide-selling business, with court records he says reflect "zero victims" — a history 404 Media recounted in August 2026 while reporting on a $345 "nuclear disaster" prescription kit Amble sells alongside its GLP-1 program. In May 2026 Amble announced an "Amble Cares" program advertising up to 50% lower cost for patients an unnamed third party verifies as low-income (press release), which Amble may end "at any time, for any reason or no reason".

How Amble Compares on Price to Providers We Track

This is an apples-to-apples comparison: Amble and the tracked programs below all dispense compounded semaglutide from licensed U.S. pharmacies with the visit included and no membership fee. The difference is price and terms.

In multiples: Amble's six-month rate is about 2.0x the cheapest tracked compounded semaglutide and its month-to-month rate about 2.6x; the landing-page tirzepatide price is about 1.9x the cheapest tracked tirzepatide. Over a year the six-month plan costs roughly $792 more than Embody. The molecule is the same whoever dispenses it: semaglutide produced 14.9% average weight loss over 68 weeks in STEP-1 (NEJM, 2021) and tirzepatide 20.9% at 15mg over 72 weeks in SURMOUNT-1 (NEJM, 2022); compounded versions of both are not FDA-approved finished products, at Amble or anywhere else.

Who Amble Suits — and Who It Doesn't